Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

376 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. Among authors: blauvelt a. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Free article. Clinical Trial.
Orismilast, a PDE4B/D inhibitor, in moderate-to-severe atopic dermatitis: Efficacy and safety from a multicenter, randomized, placebo-controlled, phase 2b dose-ranging study (ADESOS).
Silverberg JI, Eichenfield LF, Blauvelt A, Irvine AD, Guttman-Yassky E, Langley RG, Warren RB, French LE, Felding J, Weiss A, Pedersen CB, Jensen ML, Carlsson A, Sommer MOA, Kjøller K, Simpson EL. Silverberg JI, et al. Among authors: blauvelt a. Br J Dermatol. 2025 Jan 7:ljae507. doi: 10.1093/bjd/ljae507. Online ahead of print. Br J Dermatol. 2025. PMID: 39847538
Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events.
Lebwohl M, Deodhar A, Schwartzman S, Salvarani C, Feely McDonald M, Bello N, Grace EL, Inman E, Kronbergs A, Ngantcha M, Rahman P, Papp KA, Merola JF, Gottlieb AB, Blauvelt A. Lebwohl M, et al. Among authors: blauvelt a. Dermatol Ther (Heidelb). 2025 Jan;15(1):161-188. doi: 10.1007/s13555-024-01323-9. Epub 2025 Jan 22. Dermatol Ther (Heidelb). 2025. PMID: 39843709 Free PMC article.
Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis.
Blauvelt A, Kircik L, Schlesinger T, Pierce E, Burge R, Behling M, Atwater AR, ElMaraghy H, Armstrong A. Blauvelt A, et al. J Dermatolog Treat. 2025 Dec;36(1):2442720. doi: 10.1080/09546634.2024.2442720. Epub 2025 Jan 6. J Dermatolog Treat. 2025. PMID: 39761965 Free article.
Evaluation of Pharmacokinetics of Lebrikizumab in Healthy Individuals After Subcutaneous Administration Using a Prefilled Syringe or Autoinjector in a Phase 1 Randomized Study.
Datta-Mannan A, Moser B, Xu W, Jackson K, Witcher J, Armstrong AW, Blauvelt A, Lio PA. Datta-Mannan A, et al. Among authors: blauvelt a. Clin Ther. 2025 Jan;47(1):55-61. doi: 10.1016/j.clinthera.2024.10.016. Epub 2024 Dec 4. Clin Ther. 2025. PMID: 39638723 Free article. Clinical Trial.
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials.
Armstrong AW, Lebwohl M, Warren RB, Sofen H, Imafuku S, Ohtsuki M, Spelman L, Passeron T, Papp KA, Kisa RM, Vaile J, Berger V, Vritzali E, Hoyt K, Colombo MJ, Scotto J, Banerjee S, Strober B, Thaçi D, Blauvelt A. Armstrong AW, et al. Among authors: blauvelt a. JAMA Dermatol. 2025 Jan 1;161(1):56-66. doi: 10.1001/jamadermatol.2024.4688. JAMA Dermatol. 2025. PMID: 39602111 Free PMC article. Clinical Trial.
376 results